Longitudinal quantitative MRI assessment of cortical damage in multiple sclerosis: A pilot study

Quantitative MRI (qMRI) allows assessing cortical pathology in multiple sclerosis (MS) on a microstructural level, where cortical damage has been shown to prolong T1‐relaxation time and increase proton density (PD) compared to controls. However, the evolution of these changes in MS over time has not been investigated so far. In this pilot study we used an advanced method for the longitudinal assessment of cortical tissue change in MS patients with qMRI in comparison to cortical atrophy, as derived from conventional MRI.

[1]  Vinzenz Fleischer,et al.  Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2 , 2017, Brain Imaging and Behavior.

[2]  R. Deichmann,et al.  Comparison of two quantitative proton density mapping methods in multiple sclerosis , 2017, Magnetic Resonance Materials in Physics, Biology and Medicine.

[3]  Simon Baudrexel,et al.  Longitudinal changes of cortical microstructure in Parkinson's disease assessed with T1 relaxometry , 2016, NeuroImage: Clinical.

[4]  Vinzenz Fleischer,et al.  Multimodal quantitative MRI assessment of cortical damage in relapsing‐remitting multiple sclerosis , 2016, Journal of magnetic resonance imaging : JMRI.

[5]  Vinzenz Fleischer,et al.  Changes and variability of proton density and T1 relaxation times in early multiple sclerosis: MRI markers of neuronal damage in the cerebral cortex , 2016, European Radiology.

[6]  Vinzenz Fleischer,et al.  Assessment of cortical damage in early multiple sclerosis with quantitative T2 relaxometry , 2016, NMR in biomedicine.

[7]  D. Ramasamy,et al.  A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients , 2016, Multiple sclerosis.

[8]  Ralf Deichmann,et al.  Improved visibility of brain tumors in synthetic MP‐RAGE anatomies with pure T1 weighting , 2015, NMR in biomedicine.

[9]  Till Acker,et al.  A human post-mortem brain model for the standardization of multi-centre MRI studies , 2015, NeuroImage.

[10]  V. Brinar,et al.  Challenges in multiple sclerosis; how to define occurence of progression , 2013, Clinical Neurology and Neurosurgery.

[11]  Ralf Deichmann,et al.  Quantitative proton density mapping: correcting the receiver sensitivity bias via pseudo proton densities , 2012, NeuroImage.

[12]  Bruce Fischl,et al.  Within-subject template estimation for unbiased longitudinal image analysis , 2012, NeuroImage.

[13]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[14]  Ralf Deichmann,et al.  A fast B1-mapping method for the correction and normalization of magnetization transfer ratio maps at 3 T , 2010, NeuroImage.

[15]  Alan J Thompson,et al.  TI-relaxation time changes over five years in relapsing-remitting multiple sclerosis , 2010, Multiple sclerosis.

[16]  F Barkhof,et al.  Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up study , 2010, Multiple sclerosis.

[17]  R. Deichmann,et al.  T1 mapping using spoiled FLASH‐EPI hybrid sequences and varying flip angles , 2009, Magnetic resonance in medicine.

[18]  R. Deichmann,et al.  Influence of RF spoiling on the stability and accuracy of T1 mapping based on spoiled FLASH with varying flip angles , 2009, Magnetic resonance in medicine.

[19]  Nadim Joni Shah,et al.  Fast quantitative mapping of absolute water content with full brain coverage , 2008, NeuroImage.

[20]  A J Thompson,et al.  Normal-appearing grey and white matter T1 abnormality in early relapsing–remitting multiple sclerosis: a longitudinal study , 2007, Multiple sclerosis.

[21]  S. Rombouts,et al.  Voxel-based analysis of quantitative T1 maps demonstrates that multiple sclerosis acts throughout the normal-appearing white matter. , 2006, AJNR. American journal of neuroradiology.

[22]  Mark W. Woolrich,et al.  Advances in functional and structural MR image analysis and implementation as FSL , 2004, NeuroImage.

[23]  P M Matthews,et al.  MRI Brain T1 Relaxation Time Changes in MS Patients Increase Over Time in Both the White Matter and the Cortex , 2003, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[24]  G. Comi,et al.  Magnetization transfer imaging to monitor the evolution of MS , 2000, Neurology.

[25]  A M Dale,et al.  Measuring the thickness of the human cerebral cortex from magnetic resonance images. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  G. Barker,et al.  Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations , 2000, Journal of neurology, neurosurgery, and psychiatry.

[27]  F Barkhof,et al.  Neuronal damage in T1‐hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy , 1999, Annals of neurology.

[28]  S. Lynch,et al.  Ferritin, transferrin and iron concentrations in the cerebrospinal fluid of multiple sclerosis patients , 1999, Brain Research.

[29]  A. Dale,et al.  Cortical Surface-Based Analysis II: Inflation, Flattening, and a Surface-Based Coordinate System , 1999, NeuroImage.

[30]  Anders M. Dale,et al.  Cortical Surface-Based Analysis I. Segmentation and Surface Reconstruction , 1999, NeuroImage.

[31]  E M Haacke,et al.  Accurate determination of spin‐density and T1 in the presence of RF‐field inhomogeneities and flip‐angle miscalibration , 1998, Magnetic resonance in medicine.

[32]  Steven M LeVine,et al.  Iron deposits in multiple sclerosis and Alzheimer's disease brains , 1997, Brain Research.

[33]  David Katz,et al.  The relation between brain iron and NMR relaxation times: An in vitro study , 1996, Magnetic resonance in medicine.

[34]  J. Mugler,et al.  Three‐dimensional magnetization‐prepared rapid gradient‐echo imaging (3D MP RAGE) , 1990, Magnetic resonance in medicine.

[35]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.